Scientists develop a mouse model for rare brain disease Joubert syndrome

Bath scientists develop a mouse model for rare brain disease Joubert syndrome
Mouse cerebellum stained for Purkinje neurons (green). Credit: Andrew Bashford and Vasanta Subramanian.

A new mouse model for Joubert Syndrome has been developed by University of Bath scientists, who hope it will accelerate research to understand how the disease develops as well as help develop and evaluate therapeutic approaches.

Researchers from the Department of Biology & Biochemistry were able to accurately recreate the in mice through targeted deletion of portions of a gene called Talpid3 which is required for the formation of cilia—small hair-like projections seen in many mammalian cells. These projections function like cellular antenna sensing external signals. The equivalent human gene, KIAA0856 had been linked to the disease in previous studies.

The selective gene manipulation in Talpid3 reproduced the physical abnormalities of the disease in the of the mice. The also demonstrated one of the key symptoms of Joubert Syndrome—progressive ataxia which is a worsening lack of motor control. In addition, the deletion in Talpid3 impacted on some key molecular pathways associated with the formation of the cerebellum.

The paper is published in The Journal of Pathology.

Joubert Syndrome is a rare hereditary genetic disease, affecting between 1 in 80,000-100,000 people. The disease leads to the underdevelopment of the cerebellum, a region of the brain which controls balance and motor skills. Patients suffer from a range of symptoms, most commonly impaired motor control, abnormal breathing and sleep, and developmental delays as well as deformities such as or extra fingers and toes.

Dr. Vasanta Subramanian, who conducted the research with Dr. Andrew Bashford, said: "We believe that our represents the best replication of Joubert Syndrome to date, and therefore will be an excellent experimental model for scientists studying this disease, as well in the search for new therapies.

"By selectively targeting the Talpid3 gene we have reproduced the characteristic brain abnormalities of Joubert Syndrome, as well as the symptoms, like ataxia. We believe that the deletion of Talpid3 affects signalling and cell migration in the brain, which disrupts the cellular organisation of the cerebellum, which is something we will continue to investigate in our research."

More information: Andrew L Bashford et al, Mice with a conditional deletion of Talpid3 ( KIAA0586 ) ‐ a model for Joubert Syndrome, The Journal of Pathology (2019). DOI: 10.1002/path.5271

Journal information: Journal of Pathology

Provided by University of Bath
Citation: Scientists develop a mouse model for rare brain disease Joubert syndrome (2019, April 2) retrieved 25 September 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Gene editing possible for kidney disease


Feedback to editors